Psychopharmacology Maastricht

The psychopharmacology department at Maastricht University focuses on the cognitive, behavioral, and biological effects of various substances, ranging from pharmaceutical to recreational drugs.

Learn More
hero-decor

Maastricht Psychedelic Symposium

On May 24, the Maastricht Psychedelic Research Team organized a mini-symposium on psychedelics. We welcomed two international speakers: Prof. dos Santos and Prof. Bouso from Brazil and Spain to discuss their ayahuasca and ibogaine research. We also had several internal speakers: presenting on mystical vs. autobiographical psychedelic experiences (Dr Kangaslampi), microdosing (Ms. Haijen), and 5-MeO-DMT (Mr. Reckweg).

Click below to watch the entire symposium

Watch the Live Stream
img-2-intro
featured study

Read about our new paper on the neurological origins of a visual psychedelic hallucination

Congratulations to Zeus Tipado on his newly published paper that introduces a new theory as to why a person experiences a visual trip on psychedelics.

Read The Paper

Participate in our studies!

We're always conducting research in our department and we're frequently looking for participants to be a part of science! If you're interested, look at the studies that we are currently conducting.

View All Studies
img-2-intro

Dr. Malin Vedøy Uthaug

Ayahuasca, 5-MeO-DMT, Consciousness

I am an altered states of consciousness researcher from Norway and one of the world leading experts on 5-MeO-DMT.

Dr. Peter van Ruitenbeek

Dopamine, Neuroimaging

My name is Dr. Peter van Ruitenbeek and I work as an assistant professor. That means I teach and do research at the faculty of psychology and neuroscience.

Pablo Mallaroni, MSc

Psychedelics, fMRI/MRS, Idiosyncracy

I am PhD candidate with the Psychopharmacology Unit of Maastricht University with a background in translational neuroscience.

Sarah Roche, MSc

Environment, Psilocybin, Sustainability

My PhD research focuses on psychedelic drugs as a tool to investigate the cognitive mechanisms underlying changes in sustainable behavior.

Henry Whitfeld, MSc

Psilocybin, Psychotherapy, Ideography

After being a psychological therapist with 20years experience in trauma work and mindfulness-informed approaches, I am now a researcher investigating how psychedelic experiences and psychotherapeutic protocols interact.

Iva Totomanova, MSc

ADHD, LSD, Microdosing

My primary research interest lies in exploring the potential of psychedelics to be used as novel treatment options for a range of psychiatric disorders.

Zain Gangaram, MSc

RDoC, PTSD, aggression

My research is multifaceted and is based on an RDoC model for Reactive Aggression (RA).

Prof. Arjan Blokland

Cognition, Learning & Memory, Acetylcholine

I studied Psychology at the Radboud University (Nijmegen, NL). After receiving my PhD in Maastricht in 1992, I did a post doc at the University of Cambridge in 1992.

Dr. Natasha Mason

Psychedelics, Neuroadaptations, Plasticity

My research is driven by my desire to find effective treatments for psychiatric disorders, particularly anxiety, depression, and post-traumatic stress disorder.

We are always up for communicating with people that have interesting ideas or questions. If you want to contact our department, please reach out using this form below.

Copyright 2024 © Psychopharmacology Department at Maastricht University, All Rights Reserved